Developing A Collaborative Care Strategy for Depression and Co-Morbid CHF

制定针对抑郁症和共病 CHF 的协作护理策略

基本信息

项目摘要

DESCRIPTION (provided by applicant): Congestive heart failure (CHF) is a common and growing health problem that affects 5 million Americans, with over 550,000 newly diagnosed cases, 287,000 deaths, and $30 billion in direct and indirect costs yearly. Despite a number of care management programs that are being adopted by private and public payers, CHF patients continue to experience poor outcomes. A potential contributor to these poor outcomes is the presence of depression, present in approximately 20-50% of CHF patients. Similar principles of effective chronic disease management apply to both depression and to CHF. Thus, we suggest that screening CHF patients for depression and then utilizing a single nurse care manager working under a physician's supervision to simultaneously deliver evidence-based treatments for both conditions when present is a novel and potentially more sustainable strategy for improving clinical outcomes than referring depressed CHF patients to separate care providers. Our revised three-year R34 treatment development proposal is responsive to NIMH PAR-06-248, From Intervention Development to Services, as its specific aims are to obtain the necessary feasibility and clinical data required to plan a large-scale R01 trial which will compare the effectiveness of a "blended" depression/CHF care management program with current CHF care management programs in reducing depressive symptoms, improving HRQoL, and various other outcomes of interest. It consists of four coordinated phases: (1) Training; (2) Manual Development; (3) Cohort Study; and (4) Pilot Intervention. We will send nurse-recruiter/care managers from our present NIH-funded trial to treat post-CABG depression for training in two local in-patient and out-patient CHF care management programs. We subsequently will integrate the stepped collaborative care protocols for treating depression we developed in our earlier work with guideline-based protocols for treating CHF. Next, we will conduct a cohort study to estimate recruitment and "usual care" treatment patterns for 372 depressed and 100 non-depressed CHF patients. ROC analyses will be applied so as to estimate suitably sensitive and specific PHQ-9 cut-off scores for identifying depressed patients who are likely to die or become rehospitalized at 6-month follow-up. Finally, we will pilot our telephone-based "blended" collaborative care strategy to 30 depressed CHF patients to further refine our treatment strategy.
描述(由申请人提供):充血性心力衰竭(CHF)是一种常见且日益严重的健康问题,影响了500万美国人,每年有超过55万新诊断病例,287,000例死亡,直接和间接费用达300亿美元。尽管私人和公共支付方正在采用一些护理管理方案,但瑞士法郎患者的预后仍然很差。造成这些不良结果的一个潜在因素是抑郁症的存在,大约20-50%的CHF患者存在抑郁症。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A positive 2-item Patient Health Questionnaire depression screen among hospitalized heart failure patients is associated with elevated 12-month mortality.
住院心力衰竭患者的 2 项患者健康问卷抑郁筛查呈阳性与 12 个月死亡率升高相关。
  • DOI:
    10.1016/j.cardfail.2011.11.002
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    6
  • 作者:
    Rollman,BruceL;HerbeckBelnap,Bea;Mazumdar,Sati;Houck,PatriciaR;He,Fanyin;Alvarez,ReneJ;Schulberg,HerbertC;Reynolds3rd,CharlesF;McNamara,DennisM
  • 通讯作者:
    McNamara,DennisM
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BRUCE Lawrence ROLLMAN其他文献

BRUCE Lawrence ROLLMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BRUCE Lawrence ROLLMAN', 18)}}的其他基金

Methods Core
方法核心
  • 批准号:
    10435005
  • 财政年份:
    2018
  • 资助金额:
    $ 15.64万
  • 项目类别:
Methods Core
方法核心
  • 批准号:
    10631220
  • 财政年份:
    2018
  • 资助金额:
    $ 15.64万
  • 项目类别:
Blended Collaborative Care for Heart Failure and Co-Morbid Depression
心力衰竭和共病抑郁症的混合协作护理
  • 批准号:
    8437510
  • 财政年份:
    2013
  • 资助金额:
    $ 15.64万
  • 项目类别:
Blended Collaborative Care for Heart Failure and Co-Morbid Depression
心力衰竭和共病抑郁症的混合协作护理
  • 批准号:
    8710331
  • 财政年份:
    2013
  • 资助金额:
    $ 15.64万
  • 项目类别:
Online Treatments for Mood and Anxiety Disorders in Primary Care
初级保健中情绪和焦虑症的在线治疗
  • 批准号:
    8235150
  • 财政年份:
    2012
  • 资助金额:
    $ 15.64万
  • 项目类别:
Online Treatments for Mood and Anxiety Disorders in Primary Care
初级保健中情绪和焦虑症的在线治疗
  • 批准号:
    8598831
  • 财政年份:
    2012
  • 资助金额:
    $ 15.64万
  • 项目类别:
Online Treatments for Mood and Anxiety Disorders in Primary Care
初级保健中情绪和焦虑症的在线治疗
  • 批准号:
    8423688
  • 财政年份:
    2012
  • 资助金额:
    $ 15.64万
  • 项目类别:
Developing A Collaborative Care Strategy for Depression and Co-Morbid CHF
制定针对抑郁症和共病 CHF 的协作护理策略
  • 批准号:
    7253852
  • 财政年份:
    2007
  • 资助金额:
    $ 15.64万
  • 项目类别:
Developing A Collaborative Care Strategy for Depression and Co-Morbid CHF
制定针对抑郁症和共病 CHF 的协作护理策略
  • 批准号:
    7418923
  • 财政年份:
    2007
  • 资助金额:
    $ 15.64万
  • 项目类别:
Treatment of Depression Following Bypass Surgery
搭桥手术后抑郁症的治疗
  • 批准号:
    7271169
  • 财政年份:
    2003
  • 资助金额:
    $ 15.64万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.64万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 15.64万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.64万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.64万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.64万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.64万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.64万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 15.64万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 15.64万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 15.64万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了